A carregar...
Ruthenium(II) and Iridium(III) Complexes as Tested Materials for New Anticancer Agents
The oncological use of cisplatin is hindered by its severe side effects and a very important resistance problem. To overcome these problems, scientists have attempted to design new generation transition-metal anticancer complexes. In this study, we present new complexes, ruthenium(II) [(η(6)-p-cymen...
Na minha lista:
| Publicado no: | Materials (Basel) |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7475896/ https://ncbi.nlm.nih.gov/pubmed/32784666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ma13163491 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|